基于高分辨率胸部CT及人工智能中西医与西医治疗COVID-19肺内病变体积占比分析  

Analysis of the Proportion of the Volume of Pulmonary Lesions in the Treatment of COVID-19 Based on High-Resolution Chest CT and Artificial Intelligence

作　　者：杨彦鸿 雷健东 甘清鑫[1] 黄德扬[1] YANG Yan-hong;LEI Jian-dong;GAN Qing-xin;HUANG De-yang(Department of Radiology,the Eighth Affiliated Hospital of Guangzhou Medical University,Guangzhou 510440,Guangdong Province,China;Datang Street Community Health Service Center,Yuexiu District,Guangzhou 510055,Guangdong Province,China)

机构地区：[1]广州医科大学附属市八医院放射科,广东广州510440 [2]广州市越秀区大塘街社区卫生服务中心,广东广州510055

出　　处：《中国CT和MRI杂志》2023年第4期39-40,57,共3页Chinese Journal of CT and MRI

基　　金：广东省中医药局科研项目(20211303)。

摘　　要：目的 基于人工智能回顾性分析利用中西医与西医治疗170例新型冠状病毒肺炎(COVID-19)患者胸部CT肺病变体积占比。方法 收集2020年1月20日至2月23日于广州医科大学附属市八医院收治的COVID-19患者170名资料,根据治疗情况不同将其分为中西医组69例,西医组101例,观察两组患者一般临床资料、核酸转阴时间、症状恢复时间及住院天数,入院胸部CT和出院前胸部CT肺病变体积占比。结果 两组患者性别、年龄、临床分型、流行病学史及基础疾病均无统计学差异(P>0.05)。中西医组与西医组相比,临床症状恢复时间、住院日均明显缩短,两组比较具有均具有统计学差异(P均<0.05),核酸转阴时间则无统计学差异(P>0.05);两组患者入院胸部CT肺病变体积占比无统计学差异(P>0.05),出院前胸部CT肺病变体积占比中西医组比西医组略小,两组具有显著统计学差异(P<0.01)。结论 中西医结合治疗COVID-19在改善症状及缩短病程方面有明显优势。在胸部CT评价中,中西医联合治疗在肺部病灶吸收速度方面较西医治疗快。Objective Based on the retrospective analysis of artificial intelligence,the proportion of lung lesions volume of chest CT in 170 patients with new coronavirus pneumonia(COVID-19)treated with Chinese and Western medicine or Western medicine.Methods The data of 170 COVID-19 patients who were admitted to the Eighth Affiliated City Hospital of Guangzhou Medical University from January 20 to February 23,2020 were collected.According to the different treatment conditions,they were divided into a Chinese and Western medicine group with 69 cases and a Western medicine group with 101 cases.Observe the general clinical data of the two groups of patients,the time of nucleic acid conversion,the time of symptom recovery,and the days of hospitalization,and the proportion of lung lesions volume of chest CT on admission and before discharge.Results There were no statistical differences in gender,age,clinical classification,epidemiological history and underlying diseases between the two groups(P>0.05).Compared with two groups,the clinical symptom recovery time and hospitalization days were significantly shorter in the Chinese and Western medicine group and the western medicine group.There were statistical differences between the two groups(P<0.05),and there was no statistical difference in the time of nucleic acid conversion(P>0.05);There was no statistical difference in the proportion of lung lesion volume between the two groups of patients on admission(P>0.05),and the proportion of lung lesion volume before discharge was slightly smaller than that of the Chinese and Western medicine group than the Western medicine group.There was a significant statistical difference between the two groups(P<0.01).Conclusion The treatment of COVID-19 with Chinese and Western medicine has obvious advantages in improving symptoms and shortening the course of the disease.In the chest CT evaluation,the combined treatment of traditional Chinese and western medicine is faster than western medicine in the absorption rate of lung lesions.

关 键 词：新型冠状病毒肺炎 中西医 CT 人工智能 

分 类 号：R445.3[医药卫生—影像医学与核医学]